Iris Pharma is a world-class Contract Research Organization (CRO) totally dedicated to ophthalmology. Since 1989, Iris Pharma has helped bring more than 40 ocular drugs and medical devices to the American and European markets. Iris Pharma is your ideal partner to carry out proof of concept and GLP preclinical studies (tolerance, PK, efficacy), Phase I to IV clinical trials, bioanalysis and preclinical formulation development as well as to provide you with an on hand specialist consulting service.